Study of Eszopiclone Compared to Placebo in the Treatment of Insomnia Secondary to Perimenopause/Menopause

NCT00366093 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Insomnia

Interventions

DRUG: Eszopiclone
DRUG: Placebo

Sponsor

Sumitomo Pharma America, Inc.